426 related articles for article (PubMed ID: 36569836)
1. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail.
Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B
Front Immunol; 2022; 13():1074867. PubMed ID: 36569836
[TBL] [Abstract][Full Text] [Related]
2. Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail.
Wu H; Wang Y; Huang J; Li Y; Lin Z; Zhang B
Biomed Pharmacother; 2023 Feb; 158():114175. PubMed ID: 36587556
[TBL] [Abstract][Full Text] [Related]
3. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
Zhou M; Li S; Song L; Hu Q; Liu W
Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
[TBL] [Abstract][Full Text] [Related]
4. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract][Full Text] [Related]
5. Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways.
Zhong CS; Zeng B; Qiu JH; Xu LH; Zhong MY; Huang YT; Xu R; Liu SY; Zha QB; Hu B; Ou-Yang DY; He XH
Acta Pharmacol Sin; 2022 May; 43(5):1324-1336. PubMed ID: 34376811
[TBL] [Abstract][Full Text] [Related]
6. Secretion of IL-1β From Monocytes in Gout Is Redox Independent.
Alberts BM; Bruce C; Basnayake K; Ghezzi P; Davies KA; Mullen LM
Front Immunol; 2019; 10():70. PubMed ID: 30761138
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate attenuates MSU-induced gouty arthritis by inhibiting NLRP3 inflammasome activation and oxidative stress.
Cao Y; Hu Y; Jin XF; Liu Y; Zou JM
Eur Rev Med Pharmacol Sci; 2023 Jan; 27(2):628-641. PubMed ID: 36734707
[TBL] [Abstract][Full Text] [Related]
8. Development of novel NLRP3-XOD dual inhibitors for the treatment of gout.
Wang W; Pang J; Ha EH; Zhou M; Li Z; Tian S; Li H; Hu Q
Bioorg Med Chem Lett; 2020 Feb; 30(4):126944. PubMed ID: 31924495
[TBL] [Abstract][Full Text] [Related]
9. Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation
Pan YG; Huang MT; Sekar P; Huang DY; Lin WW; Hsieh SL
Front Immunol; 2021; 12():638676. PubMed ID: 33746978
[TBL] [Abstract][Full Text] [Related]
10. Lipoxin A4 attenuates MSU-crystal-induced NLRP3 inflammasome activation through suppressing Nrf2 thereby increasing TXNRD2.
Zhou Y; Chen Y; Zhong X; Xia H; Zhao M; Zhao M; Xu L; Guo X; You CG
Front Immunol; 2022; 13():1060441. PubMed ID: 36569930
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation.
Wang Y; Zhu W; Lu D; Zhang C; Wang Y
Int Immunopharmacol; 2021 Nov; 100():108107. PubMed ID: 34482265
[TBL] [Abstract][Full Text] [Related]
12. Curcumin ameliorates monosodium urate-induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling.
Li X; Xu DQ; Sun DY; Zhang T; He X; Xiao DM
J Cell Biochem; 2019 Apr; 120(4):6718-6728. PubMed ID: 30592318
[TBL] [Abstract][Full Text] [Related]
13. Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
Lee HE; Yang G; Kim ND; Jeong S; Jung Y; Choi JY; Park HH; Lee JY
Sci Rep; 2016 Dec; 6():38622. PubMed ID: 27934918
[TBL] [Abstract][Full Text] [Related]
14. Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia.
Elsaid K; Merriman TR; Rossitto LA; Liu-Bryan R; Karsh J; Phipps-Green A; Jay GD; Elsayed S; Qadri M; Miner M; Cadzow M; Dambruoso TJ; Schmidt TA; Dalbeth N; Chhana A; Höglund J; Ghassemian M; Campeau A; Maltez N; Karlsson NG; Gonzalez DJ; Terkeltaub R
Arthritis Rheumatol; 2023 May; 75(5):794-805. PubMed ID: 36457235
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice.
Xue Y; Li R; Fang P; Ye ZQ; Zhao Y; Zhou Y; Zhang KQ; Li L
J Mol Endocrinol; 2021 Jun; 67(2):27-40. PubMed ID: 34047713
[TBL] [Abstract][Full Text] [Related]
16. Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.
Yang G; Yeon SH; Lee HE; Kang HC; Cho YY; Lee HS; Lee JY
Rheumatology (Oxford); 2018 Apr; 57(4):727-736. PubMed ID: 29340626
[TBL] [Abstract][Full Text] [Related]
17. Role of NLRP3 in the pathogenesis and treatment of gout arthritis.
Liu YR; Wang JQ; Li J
Front Immunol; 2023; 14():1137822. PubMed ID: 37051231
[TBL] [Abstract][Full Text] [Related]
18. Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathway.
An MF; Wang MY; Shen C; Sun ZR; Zhao YL; Wang XJ; Sheng J
J Nat Med; 2021 Jan; 75(1):129-141. PubMed ID: 33188510
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.
Amaral FA; Costa VV; Tavares LD; Sachs D; Coelho FM; Fagundes CT; Soriani FM; Silveira TN; Cunha LD; Zamboni DS; Quesniaux V; Peres RS; Cunha TM; Cunha FQ; Ryffel B; Souza DG; Teixeira MM
Arthritis Rheum; 2012 Feb; 64(2):474-84. PubMed ID: 21952942
[TBL] [Abstract][Full Text] [Related]
20. Lower Temperatures Exacerbate NLRP3 Inflammasome Activation by Promoting Monosodium Urate Crystallization, Causing Gout.
Ahn H; Lee G; Lee GS
Cells; 2021 Jul; 10(8):. PubMed ID: 34440688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
